Cerus Inc (CERS) Narxning foydaga nisbati

Cerus Corp - CERS emitenti grafik logotipi

Cerus Corporation (CERS) INTERCEPT tizimi tufayli shifokorlar orasida mutlaq nufuzga ega bo'lib, qon xavfsizligi bo'yicha global etalon sifatida tan olingan. Cerus Corporation donor materiallaridagi patogenlarni hujayralarga zarar yetkazmagan holda kamaytirishning noyob usuli orqali bozorni nazorat qiladi. Patent himoyasi va yuqori o'tish xarajatlari kompaniyaga o'zining narx belgilash imkoniyati orqali inflyatsiyani iste'molchilarga osonlikcha yuklash imkonini beradi. P/E koeffitsiyenti uchun bozor tendentsiyasi -55.10 darajasida turibdi.

Cerus (CERS) - P/E multiplikatori 04.07.2022dan 16.11.2026gacha

Cerus Corporation kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning umumiy tahlili:Cerus Corp., CERS
Cerus Corporation tovar namunasi

P/E koeffitsiyenti sof foydaning bir birligining bozor qiymatini belgilab, aktivning haddan tashqari baholanganlik darajasini ko'rsatadi. Hisoblangan narx-foyda koeffitsiyentining dinamikasi moliyaviy hisobotlar e'lon qilingandan so'ng kompaniyaning fundamental sifatini tezkor baholash imkonini beradi. Ushbu metrika aksiya narxlarining aksiya uchun foyda nisbati orqali investitsiyalarning qoplanish muddatini o'lchaydi. Cerus Corporation (CERS) uchun barqaror P/E qon xavfsizligi sektoridagi B2B mijozlar ustidan monopoliya nazoratiga ega bo'lganligi sababli biznesning yuqori qiymatini tasdiqlaydi.

Raqobatdosh kompaniyalar tahlili

P/E multiplikatori Intuitive Surgical, Inc.|Narx-foyda koeffitsiyenti DHR (Danaher Corp)|BDX (Becton, Dickinson and Company) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori STE (steris.com)|Biznesning o‘zini qoplash muddati westpharma.com (WST)|BAX - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Masimo Corp MASI|Stevanato Group S.p.A. (STVN) - Narxning foydaga nisbati|TFX - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati merit.com|Envista (NVST) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti ICUI (ICU Medical, Inc.)|Bozor narxining sof foydaga nisbati XRAY|Narxning foydaga nisbati LeMaitre LMAT|Kompaniya qiymatining sof foydaga nisbati ATRC|STAA: Narx-foyda koeffitsiyenti|NAGE - P/E multiplikatori|ZimVie Inc (ZIMV) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti AngioDynamics|TKNO (teknova.com) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Monogram Orthopedics Inc. MGRM|Narxning foydaga nisbati Sharps Tech (STSS)|InfuSystem Inc - Narx-foyda multiplikatori|Utah Medical Products - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati KRMD (KORU Medical Systems)|NYXH - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Microbot Medical, Inc MBOT|Pro-Dex Corp (PDEX) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati ZTEK (Zentek Ltd.)|Narxning foydaga nisbati Elutia|Milestone Scientific Inc (MLSS) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti NXGL (NEXGEL, Inc.)|RVP (Retractable Technologies, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Harvard Bioscience, Inc. - Narx-foyda koeffitsiyenti|P/E multiplikatori femasys.com FEMY|MHUA: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati predictive-oncology.com POAI|Callan JMB Inc (CJMB) - Narxning foydaga nisbati|Narx-foyda multiplikatori ATRI|NURO (NeuroMetrix Inc) - P/E multiplikatori